Capricor Therapeutics is expected to release data from the phase 3 HOPE-3 trial in Q3'25, thus presenting a potential path ...

IV therapy clinics have been on a growth spurt, offering drips that promise to boost energy, gird immune systems or relieve ...

Dermatologists explain which therapies to avoid, which to keep even as they campaign for a regulatory mechanism for ...